Thank you Tracy and good morning. In the fourth quarter, we continue to effectively leverage the favorable market conditions and achieved strong quarterly results which topped off a great year with record core income.

Before I provide details, let me offer a few highlights on both periods. Our gross written premiums excluding our captive business grew by 16% in the fourth quarter and 10% for the full year.\ Importantly, the overall P&C rate increase remained at 8% in the fourth quarter consistent with the third quarter, leading to a full year rate increase of 9% which was well above long run loss cost trends.

The all in combined ratio was 92.9% for the quarter and 96.2% for the year, each representing the best ratios in five years. Our underlying combined ratio was 91.2% for the quarter, and a record low of 91.4% for the full year.

All of this led to record core income of just over $1.1 billion for the year, up 50% in core EPS of $4.06 per share. Drilling down on the details starting with the fourth quarter, our P&C operations produced core income of $353 million, or $1.29 per share.

Our Life & Group segment produced core income of $6 million, and our Corporate & Other segment produced a core loss of $94 million, mainly impacted by a non-economic charge related to asbestos and environmental. As usual, Larry will provide more details on Life & Group and the corporate segments.

In the fourth quarter, the all in combined ratio was 92.9%, a half a point lower than the fourth quarter of 2020, and the lowest all in quarterly combined ratio since 2016. Pretax catastrophe losses in the quarter were $40 million or two points of the combined ratio, compared to $14 million in the prior year period.

The P&C underlying combined ratio of 91.2%, 1.4 point improvement over last year's fourth quarter result. The underlying loss ratio in the fourth quarter of 2021 was 60.1%, which is down 0.3 points compared to the fourth quarter of 2020.

Excluding the impacts of COVID in the prior year quarter, the underlying loss ratio improved by 0.8 points as we continue to recognize some of the margin build in the current accident year from the earned rate increases as we did last quarter. For P&C overall, prior period development was favorable by 0.3 points on the combined ratio.

Turning to production, gross written premium, excluding our captive business grew by 16% in the fourth quarter, which was twice as high as the first half of the year. Net written premium grew by 11% for the quarter, an increase of 6 points from the third quarter.

New business grew by 28% in the quarter, and the overall written rate increase was 8% while earned rate in the quarter was 10%. In addition, retention of 83% was higher than it's been all year.

And the strong production results were broad based across all the operating segments. In terms of the business units, the all in combined ratio for specialty was 89.9% and the underlying combined ratio was 90.1%, a 0.5 improvement compared to last year.

The underlying loss ratio improved by 0.9 points to 59.1%. The expense ratio increased by 0.5 points to 30.9 from a onetime true up and Larry will provide more detail in the discussion on expenses.

Gross written premium ex-captives grew 15% in the fourth quarter with 58% growth in new business. This is the sixth consecutive quarter of double digit growth in specialty.

We also achieved an overall rate increase of 11%, up one point from the third quarter. We achieved higher rate in management liability and our affinity programs and stable rate in our health care business.

In addition, retention improved three points to 83%. Turning to commercial, the all in combined ratio was 94.9% in the quarter, including 2.9 points of Cat.

This was the lowest all in combined ratio in four years. Down the line, combined ratio was 92.2% this quarter, which was the lowest on record, and was 1.4 points lower than the fourth quarter of 2020, and 2.4 points lower excluding the COVID frequency impacts, and lower the loss ratio in 2020.

The underlying loss ratio of 661.4% improved by 0.3 points, compared to the fourth quarter 2020, excluding the COVID frequency effects. As we referenced last quarter, the underlying loss ratio for commercial was higher in the latter half of 2021 resulting from mixed change between property and casualty net earned premium due to the new property quarter share treaty we purchased in June.

Expense ratio improved 2.3 points to 30.4% this quarter. Commercial achieved that 19% growth in gross written premiums ex-captives with 16% growth in new business.

Rate at 5% was only slightly below the third quarter, and excluding work comp, the rate change was plus 7% in the quarter, which was consistent with the third quarter. Retention was up two points to 84%, which was the highest of any quarter this year.

Retentions were strong in all of our commercial business units, and middle market retention improved to 85%, just the highest level since prior to the pandemic. Exposure change was plus 2% in commercial this quarter as a result of increases in payrolls and sales volumes as the economy continues to improve, this is the highest exposure increase since the first half of 2019.

For International, the all in combined ratio was 94.8% in the quarter. The underlying combined ratio improved by 4.2 points to another record low of 90.9% this quarter.

The expense ratio improved to 2.6 points, to 32.4% and the underlying loss ratio improved 1.6 points to 58.5%. We are very pleased with the improvement in our international results, which highlights our disciplined approach to the re-underwriting and catastrophe exposure reduction we executed.

International achieved a 9% growth in gross written premium and new business growth of 15%. Rates were up 13% this quarter, achieving double-digit rate for the seventh consecutive quarter and nine of the last 10 quarters.

In addition, retention at 82% was the strongest quarterly retention in over three years. Now, let me provide some perspectives on the full year performance.

As I mentioned before, core income was a record for the year increasing 50% to a little over 1.1 billion or $4.06 per share. And net income for the year was just over $1.2 billion or $4.41 per share, this compares to 735 million and 690 million in 2020 respectively.

The increase from the prior year is attributed to significantly improved underlying underwriting gain. And while still substantial, a lower level of Cat loss compared to 2020 as well as higher net investment income driven by limited partnership returns.

The all in combined ratio was 96.2% with 5.1 points of catastrophe loss and 0.3 points of favorable prior period development. This is the lowest calendar year combined ratio in five years, and a significant accomplishment considering that heavy levels of catastrophe loss again this for this year.

Cat losses were $397 million pretax in 2021 compared to $550 million last year, but catastrophe losses in 2021 are actually higher than the $355 million catastrophe result in 2020 when your account for the COVID Cat charge we incurred in 2020. Our P&C underlying underwriting profit for the full year increased 31% to $667 million as the underlying combined ratio improved to 1.7 points to 91.4%.

It's the fifth consecutive year of improvement in the underlying combined ratio. The underlying loss ratio in 2021 was 60%, down 0.2 points compared to 2020 excluding the effects of COVID in the prior year, the underlying loss ratio improved by 0.6 points.

The expense ratio improved to 1.5 points for the full year. All three operating segments produced the strong underlying results in 2021.

For Specialty, the underlying combined ratio of 89.7% was the best on the record and 1.6 points lower than 2020. Commercial produced an underlying combined ratio of 92.6% in 2021, which is also a record and 1.3 points lower than 2020.

Multiple years of re-underwriting initiatives in our international portfolio have paid off and underlying combined ratio of 92.1% in 2021, 3.5 points lower than 2020. Turning to production for the full year, gross written premium growth ex-captives was 10% this year.

We achieved strong new business growth of 19% and a full year rate increase of 9%. Retention was 82% for the full year.

Net written premium grew by 5% for the year. In terms of the wider spread between gross and net written premium for the year compared to 2020, this is a function of the new property quarter share treaty agreement, which was on a risk attaching basis, causing the spread to widen.

Before I turn it over to Larry, I'd like to acknowledge Scott Lindquist is also on our call. He'll be transitioning with Larry through the first quarter and we'll be handling the earnings calls after the first quarter.

We are excited to have Scott on board. And with that, I'll turn it over to Larry.

Good morning, everyone. I will provide some additional information on the results as Dino indicated.

Starting with core income for the fourth quarter, our P&C operations produced a core income of $353 million as Dino indicated, a key contributor to the strong result was our pretax underlying underwriting income of $167 million, a 22% increase from the fourth quarter of 2020. In addition, our catastrophe losses are relatively modest at $40 million pretax, but despite the fact that estimated Cat losses for the industry were significantly above the 10-year median for fourth quarter events.

For full year 2021, record core income of $1.106 billion produced an ROE of 9.1%, up substantially from 2020s 6.1%. Our Q4 expense ratio was a key component of our higher, underlying, underwriting profits.

For the fourth quarter of 2021, expense ratio was 30.8%, which was 1.2 points lower than the fourth quarter of 2020. In Specialty, the expense ratio increased slightly in the quarter by half a point compared to a year ago, due to recognition of higher profit sharing in the quarter for one of our profitable programs.

In commercial, the expense ratio improved by 2.3 points this quarter, largely from growth in net earned premium. International also showed significant year-over-year improvement of 2.6 points derived by net earned premium growth and lower acquisition cost.

On an annual basis, the expense ratio was 31.1% in 2021, 1.5 points lower than full year 2020. We believe 31% is a reasonable run rate going forward as we continue to make investments in talent, technology and analytics.

The expense ratio improved for each segment with specialty improving 0.8 points from 31.3% to 30.5%, commercial improving almost two core points from 33% in 2020 to 31.1% in 2021 and international improving 2.4 points from 35.5% for 2020 to 33.1% for 2021. Moving to prior period development.

For the fourth quarter, the overall property and casualty net prior period development impact on the combined ratios was 0.3 points favorable compared to no impact in the prior year quarter. Favorable development was driven by Surety in the specialty segment for more recent action here somewhat offset by management and professional liability.

In the commercial segment, favorable development and workers compensation was offset by unfavorable development in auto and general liability. In the international, favorable developed in our commercial classes was offset by unfavorable development in our specialty classes.

In terms of our COVID reserves, we made no changes to our overall COVID catastrophe loss estimates during the quarter. We continually review our COVID reserves in our previously established estimate of ultimate losses in LAE remains appropriate, the majority of the loss estimate remains in IBNR.

For the full year 2021 overall development was favorable by three tenths of a point compared to 0.7 points favorable in 2020. The pay to incur ratio of 0.89 was elevated into four relative to the first three quarters of 2021 due largely to pay out of catastrophes that occurred in prior quarters.

However, the 0.89 ratio remains at the lower end of our pre-pandemic range. The ratio which fluctuates quarter-to-quarter has been consistently lower over the past two years, with several factors driving that, including our growth in underlying, underwriting profits.

We've also had lower non cap paid losses across several product lines, where we have taken significant underwriting actions such as our medical malpractice and excess liability lines that we have previously discussed with you. The slowdown in the court docket has also contributed to the lower paid losses.

On a full year basis, the paid to incurred ratio was 0.78. Moving to our non-Property & Casualty segments, our corporate segment produced a core loss of $94 million in the fourth quarter, which compares to a $49 million core loss in the fourth quarter of 2020.

The loss for fourth quarter 2021 was predominantly driven by our annual asbestos and environmental reserve review completed during the quarter. The results of the review included a non-economic after tax charge of $48 million driven by the strengthening of reserves associated with higher defense and indemnity costs on existing accounts, and compares the last years non-economic after tax charge of $39 million dollars.

From a core income perspective, the impact of the fourth quarter 2021 charge was a reduction of approximately $0.18 per share, versus an approximate reduction of $0.14 per share impacts in the fourth quarter of 2020. Following this year's review, we have incurred cumulative losses of $3.4 billion, which is well within the $4 billion limit of our loss portfolio transfer cover that we purchased in 2010.

Importantly, paid losses are at $2.2 billion. You will recall from previous years reviews that there's a timing difference with respect to recognizing the benefit of the cover relative to incurred losses, as we can only do so in proportion to the paid losses recovered under the treaty.

The loss recognized today will be recaptured over time through the amortization of a deferred accounting gain, as paid losses ultimately catch up with incurred losses. As of yearend 2021, we have $429 million of deferred gain that will be recaptured over time.

In addition to the impact from our annual investment, asbestos and environmental reserve review, net investment income in the fourth quarter attributed to our core corporate segment is down $13 million after tax on a year-over-year basis due to loss portfolio transfer agreement we entered into the end of last year related to legacy extra excess workers comp reserves. We also strengthened our legacy mass tort IBNR reserves this quarter by $16 million on an after tax basis.

For Life & Group we had core income of $6 million for the fourth quarter of 2021, which is $20 million lower than last year's fourth quarter, as those results benefited from favorable morbidity experience driven by the pandemic. I wanted to comment on the approaching change in GAAP accounting methodology related to long duration targeted improvements or LDTI, which will apply to our Life & Group businesses.

We will adopt this new accounting guidance effective January 1, 2023 and we'll apply it as of January 1 2021. We're working diligently on this implementation and intend to discuss the impacts on our first quarter call.

We do expect the impact of this change will be a material decrease in accumulated other comprehensive income predominantly being driven by the difference between the expected interest rates from our investment strategy and the liability discount rate assumptions required under this accounting change. This accounting pronouncement applies only to GAAP basis financial statements and has no statutory accounting or cash flow impacts on the businesses.

As a result, this accounting changes viewed by us and the industry as noneconomic as none of the fundamentals of the businesses are changed by it. Turning to investments, total pretax net investment income was $551 million in the fourth quarter, essentially the same as last year's fourth quarter.

The results included income of $108 million from our limited partnership or LP and common stock portfolios as compared to $114 million on these investments from prior year quarter. The strong LP returns for the quarter across both the P&C and Life & Group segments are significantly driven by private equity bonds and reflected the lag reporting results from the third quarter.

As a reminder, our private equity funds which comprise approximately two thirds of our LP portfolio, primarily report results on a three month lag basis, whereas our hedge funds are on a real time basis. Our fixed income portfolio continues to provide consistent net investment income, stable relative for the last few quarters and the prior year quarter.

While the current low interest rate environment continues to be a headwind, the impact on our net investment income has been mitigated by our strong operating cash flows, which have been driven by our growth and premium volume, strong underwriting profitability, and the slower pay out of losses that I previously discussed. Pretax net investment income for the full year 2021 was $2.2 billion, compared to $1.9 billion for 2020.

The increase was largely driven by our LP and common stock investments, which had pretax returns of $402 million for 2021 compared $144 million for 2020. The returns from our fixed income securities portfolio was essentially the same for 2021 as it was for 2020 as our higher asset base offset the lower average portfolio yields.

Our average book value has increased $1.4 billion from year end 2020, while the pretax effective income yield decreased 20 basis points. To give a sense of magnitude of the increase in our operating cash flow, in the fourth quarter, operating cash flow was strong once again at $643 million, and on a full year basis it increased approximately $860 million from full year 2020 after adjusting for the payment to purchase our excess workers comp LBT [Ph] agreement.

From a balance sheet perspective, the unrealized gain position of our fixed income portfolio was $4.4 billion at year end, down from $4.8 billion at the end of third quarter, reflecting the slightly higher interest rate environment. Fixed Income invested assets that support our P&C liabilities and Life and Group liabilities had effective durations of 4.9 years and 9.2 years, respectively at year-end.

Our balance sheet continues to be very solid. At year-end, shareholder’s equity was $12.8 billion or $47.20 per share, $47.20 per share.

Shares holders equity excluding accumulated other comprehensive income was $12.5 billion, or $46.02 per share, an increase of 10% from year end 2020 adjusting for dividends. We have a conservative capital structure with a level of leverage ratio of 18% and continue to maintain capital above target levels in support of our ratings.

We are still digesting the potential changes to the S&P capital model. And we do --although we do not currently see this back to changing.

Of course the final version of the model has not been determined and S&P has determined the deadline for companies to provide feedback. We continue to work with them to fully understand the potential impact of the proposed changes.

Finally, we are pleased to announce we are increasing our regular quarterly dividend 5% to $0.40 per share, which will be payable on March 10, the shareholders of record on February 22. In addition to the increase in our regular quarterly dividend, we're declaring a special dividend of $2 per share, also payable on March 10, to shareholders of record on February 22.

With that, I will turn it back to Dino.

Before opening the call to the Q&A session, I'd like to offer a few comments about how we perceive the marketplace dynamics might involve, might evolve in 2022. Most importantly, we see pricing remaining favorable with overall rate increases, persisting above long run lost cost trends for most of 2022 in light of the oft quoted headwinds, like social inflation and economic inflation and elevated cat activity, all of the headwinds are still present, there has been no significant changes since last quarter.

The uncertainty these factors create a loss cost trends have only been exacerbated by the Omicron variant, which has slowed the full return of court activity and docket logs to a pre-pandemic level, just why we have continued to prudently recognize margin improvement in our current accident year loss ratio. And although written rate increases in the last 8 to 10 quarters have allowed us to make up most of the last ground from 2015 when the rate versus loss cost trend started to become a headwind, it can easily become insufficient if loss costs trends increase further.

And this is why we are focused on pushing for more rate and where needed additional improvements in terms and conditions. As I mentioned earlier, our pricing remained stable for the third quarter at eight points while retention increased two points.

So even though rates have moderated from their high watermark in the fourth quarter of 2020, we believe the pace down will be slower than the pace rates increased. Finally, as seen by our increasing overall growth as well, as well as our growth in new business as the year progressed, we are bullish about our continued prospects, and meaningful levels of quality business to our portfolio in 2022.

And with that, we will take your questions.

Yes, thank you. So listening on prior calls and this one to you spoke about the need to perhaps increase the loss cost trend assumptions based on what you're seeing in the marketplace.

But of course, we all talked about the risk from dockets opening up and accruing [Ph] more losses. At the time that the courts were closed in the dockets were thin, what data was coming in that said that you know, what we need to increase our loss trend.

Was it more or less a hunch? Or did you actually see underlying a court data saying that court decisions are getting more generous to the plaintiffs’ [Indiscernible]?

Josh, the way I would answer it is based on some of the information we talked to you about originally, with lines like medical malpractice, and some of the auto liability, as we have a portion of the portfolio in construction, which wasn't as impacted by the COVID benefits, and also just umbrella and what we were seeing at the time, even before the pandemic, and then it continued in those lines through the pandemic, in particular professional liability. You saw things like a little bit higher attorney representation on cases, which also might have led to some additional frequency of cases potentially interested in being litigated.

You saw higher settlement demands, even when the facts of the case didn't warrant it. And so, those are the kinds of things that that, despite, the dockets being lower, it's got implications, on settlement values.

And we saw that and we continued to move our long run loss cluster. In the last quarter, you also recall, we increased our property, long run loss cost trends, about two points that had less to do, obviously, with dockets, and had to do with our view that, economic inflation, supply chain issues would probably continue.

So, there's a dynamic in particular in lines like medical malpractice that started before the pandemic and continued through it in terms of settlements that we saw.

And if I try and think about that, in terms of the stock at issue and paid to incurred ratio. I mean, nobody really knows.

But do you have any advice for us in thinking about how to think about pay to incurred ratio in 22 and 23, given that the courts will presumably reopen?

Yes, I'll give it -- to Josh, let Larry jump in his things, considerable amount of time on these fees to incurred ratios.

Yes, Josh, we spend a lot of time thinking about that as well. I can assure you of that.

And it really is difficult to parse between them right now, which is why we have been prudent about it. But as we look at it, as I mentioned in my remarks, where we have seen lower non cat paid ratios and paid loss dollars actually, is in product lines, where we have taken pretty significant underwriting action, like medical malpractice in some of our excess liability lines, particularly with auto exposures.

So it's really hard for us to try and separate what the difference is between those. But we do know that the paid to incurred loss ratio was down significantly from pre-pandemic days.

And, we're just being cautious about recognizing any of that potential improvement if it exists until we know more about what's happening as those dockets open back up.

Alright, well, we will certainly find out more. Thank you for the color.

Yes. Good morning, I wanted to focus on the areas where the rates are moving up.

More noticeably that would be financial lines in the specialty segment and small commercial in the commercial segment. Is there something particular going on that's making those move up and accelerate compared to some of the other segments or lines?

Yes, there's a little bit on each. I mean, clearly on the financial lines, which includes our cyber, cyber has been accelerating, the rate increase.

And if you look at it in the fourth quarter, we actually got triple digit rate increase. And, and the other lines, had some more stable sort of behaviour.

On the small business, Gary, we, it's on our BOP policy, we had filed for a few points of rate increases, we also got three points of exposure change and our retentions also up. So, it's all sticking.

So it's really just filings in the BOP policy on small business.

Thank you. And if I look at the growth, I think you did mention in commercial about the exposure increases, but just across the whole, whole business is -- can you somehow parse out the amount of exposure increase we're seeing versus rate or other factors?

Well, in commercial, we got about two points of exposure growth. And that was, I think I may have mentioned in the prepared remarks, really just, you're seeing more in the way of sales, you're also seeing payroll increases.

You have underwriting actions that work against that. A little bit, it's hard to know exactly.

But, our sense is we probably had a point reduction in exposure and commercial due to our underwriting actions. And, and so maybe you're looking at three points in the absence of that, which I think is, sort of reflective of the economic activity that's about, the sort of best detail I can offer there on the exposure again.

That's great. Thank you.

And, and one other thing on more on the loss trends. I’m just thinking about your loss picks for the full year, were there any adjustments or true ups that you kind of changed your view at all, and as you look back at 2021, in any of the segments or areas?

No, there was nothing really significant at all in the quarter. And when we looked at the long run loss cost strains, which obviously, despite the name of long run, we look at -- all the time, and the reality is still relatively in line with what the changes we had made in the third quarter.

So there was nothing in the way of any meaningful true ups.

Okay, great. And one last little one, can you remind us what your COVID reserves actually are at this point?

Yes, Gary, they're $195 million. That was the original.

That was the original estimate. We held that.

Right. Okay, and was some of that recognized in 2021?

Or was all that in 2020?

That was the initial estimate we put up, and we still comfortable with that. Yes, we never moved it from there.

Right.

Great. Thank you very much.

Thanks, Gary.

Thank you.

Great. Thank you.

Good morning. I want to follow up on Gary’s question with the exposure unit growth.

In your view, is that exposure unit growth likely to have any impact on the loss ratio?

Meyer, we are struggling to hear you, but are you asking what the impact on the loss ratio is from the exposure growth?

Sort of. I’m asking whether you expected to have an impact on exposure unit growth?

I'm sorry, I'm the -- I mean, it's like asking whether exposure unit growth should have an impact on the loss ratio going forward?

It's minimal right now. I mean, certainly when you think about workers comp, and you think about payroll, what's going up?

Is it is it salaries going up? And how is the salaries that you're insuring compared to average weekly wage, versus just growth in number of employees, right.

Because if it's, if it's just payroll going up the average amount being paid, and you're above the average weekly wage, it would have some benefit. But we haven't really incorporated any benefit into to our loss ratios from that.

Okay, now that's helpful. On Dino, you talked about inflation, and obviously, it's everywhere.

I was hoping you could zero in maybe on whether the various forms of inflation that we're seeing now are likely to translate into above average loss trend on the Affinity business?

And so on inflation is on the social inflation side, you're referring to Meyer?

So I'm trying to incorporate like or just to see whether any, like, because there's so many different aspects of inflation now, and most of them seem to be getting worse, whether any of those matter to Affinity?

Yes, on Affinity. We've talked a little bit about it before Meyer in the context of social inflation, because it's all professional liability.

Our Affinity programs and as I think, I've indicated before, these programs largely comprise of, of single practitioners like nurses and they typically their coverage is largely supplementary to the facilities. And rarely is there any singular accountability to the practitioner and the facilities at higher limits where typically, you see the plaintiffs go after from a social inflation.

So it's clearly had a lot less impact on the Affinity portfolio, even within the med mal side of it, than it did on the regular health care portfolio. And it's mainly there that we focus on given its professional liability.

Okay, perfect. I'm all set.

Thank you very much.

Okay thank you everyone. And we look forward to chatting with you next quarter.